JPRN-UMIN000042202已完成未知
Body mass index and medication utilization in migraine - Body mass index and medication utilization in migraine
适应症
试验速览
- 阶段
- 未知
- 状态
- 已完成
- 入组人数
- 20,000
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Others,meta-analysis etc
入排标准
- 年龄范围
- ot applicable 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •1) Patients with standard insurance diagnosis of primary headache disorders except for migraine and/or tension type headache 2) Patients with standard insurance diagnosis of secondary headache disorders except for medication overuse headache 3) Patients with standard insurance diagnosis of painful cranial neuropathies and/or other facial pain and other headaches
研究者
相似试验
招募中
不适用
Clinical implication of body mass index in patients with acute myocardial infarctioAcute myocardial infarctionJPRN-UMIN000044661Kindai University1,200
招募中
不适用
Effect of BMI and body fat percentage on pharmacokinetics and analgesic effect of fentanyl after trasndermal fentanyl patch administratiocancer-related painJPRN-UMIN000009346Kanazawa University Hospital50
已完成
不适用
Body Mass Index (BMI) and Metabolic Changes Following Switch to Aripiprazole From Olanzapine, Risperidone and QuetiapineMood DisordersSchizophreniform DisorderSchizophreniaSchizoaffective DisorderNCT00312598University of North Carolina, Chapel Hill30
已完成
Unknown
Effect of body mass index on health- related physical fitness in school going children of north and south mangaluruCTRI/2023/03/050957itte Institute of Physiotherapy166
已完成
不适用
Effect of Body Mass on Filgrastim PharmacokineticsNeutropeniaHematological MalignancyNCT01719432Aaron Cumpston, PharmD, BCOP30